EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Significant kidney disease in pregnancy: Feasibility and outcomes of a national population‐based study using the Australasian Maternity Outcomes Surveillance System

Shilpanjali Jesudason iD, Nadom Safi iD, Zhuoyang Li, Mark Brown, William Hague iD, Angela Makris, Stephen McDonald, Michael J Peek, Elizabeth Sullivan

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2025

DOI: 10.1111/ajo.13885 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2025. Verfasst von Shilpanjali Jesudason und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pregnancy and Kidney Research Australia, Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital and Faculty of Health a…. Hauptthemen laut MEDLINE: Pregnancy Complications, Renal Insufficiency, Chronic, Acute Kidney Injury. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Royal Adelaide Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current understanding of clinical practice and care for maternal kidney disease in pregnancy in Australia is hampered by limitations in available renal‐specific datasets.

Aims

To capture the epidemiology, management, and outcomes of women with significant kidney disease in pregnancy and demonstrate feasibility of a national cohort study approach. Materials and Methods An Australian prospective study (2017–2018) using a new kidney disease‐specific survey within the Australasian Maternity Outcomes Surveillance System (AMOSS). Women who gave birth with acute kidney injury (AKI), advanced chronic kidney disease (CKD), dialysis dependence or a kidney transplant were included. Demographic data, renal and obstetric management, and perinatal outcomes were collected.

Results

Among 58 case notifications from 12 hospitals in five states, we included 23 cases with kidney transplant ( n = 12), pre‐existing CKD ( n = 8), newly diagnosed CKD ( n = 2) and dialysis ( n = 1). No cases of AKI were reported. Reporting rates were better in states with study investigators and, overall, cases were likely under‐reported. Nearly 35% of women had a non‐delivery‐related antenatal admission. Nephrology involvement was 78.3% during pregnancy and 91% post‐partum. Adverse events were increased, including pre‐eclampsia (21.7%), and preterm birth (60.9%). Women had high rates of aspirin (82.6%) and antihypertensive (73.9%) use, indwelling catheter for labour/delivery (65.2%), caesarean delivery (60.9%), and blood transfusion (21.7%).

Conclusions

This first‐ever Australian prospective study of significant kidney diseases in pregnancy provided novel insights into renal‐specific clinical patterns and practices. However, under‐reporting was likely. Future studies need to overcome the challenges of case identification and data collection burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy ComplicationsRenal Insufficiency, ChronicAcute Kidney InjuryHumansFemalePregnancyAustraliaProspective StudiesAdultFeasibility StudiesKidney TransplantationPregnancy OutcomeRenal DialysisYoung Adult

Stichwörter der Autor:innen

acute kidney injurychronic kidney diseasekidney failureobstetricpregnancy

Autor:innen und Institutionen

  • Pregnancy and Kidney Research Australia, Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital and Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Austr…
  • Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia.
  • School of Medicine and Public Health, Central Coast Clinical School, The University of Newcastle, Gosford, New South Wales, Australia.
  • College of Health, Medicine and Wellbeing, University of Newcastle, Newcastle, New South Wales, Australia.
  • Department Renal Medicine and Medicine, St. George Hospital and University of New South Wales, Sydney, New South Wales, Australia.
  • Department of Renal Medicine, Liverpool Hospital, Sydney, New South Wales, Australia.

ORCID-Profile: Shilpanjali Jesudason, Nadom Safi, William Hague

Förderung

  • Royal Adelaide Hospital

Zitieren

APA

Jesudason, S., Safi, N., Li, Z., Brown, M., Hague, W., Makris, A., McDonald, S., Peek, M. J., & Sullivan, E. (2025). Significant kidney disease in pregnancy: Feasibility and outcomes of a national population‐based study using the Australasian Maternity Outcomes Surveillance System. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.13885

Vancouver

Jesudason S, Safi N, Li Z, Brown M, Hague W, Makris A, et al. Significant kidney disease in pregnancy: Feasibility and outcomes of a national population‐based study using the Australasian Maternity Outcomes Surveillance System. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2025. doi:10.1111/ajo.13885

BibTeX
@article{Jesudason2025,
  author = {Jesudason, Shilpanjali and Safi, Nadom and Li, Zhuoyang and Brown, Mark and Hague, William and Makris, Angela and McDonald, Stephen and Peek, Michael J and Sullivan, Elizabeth},
  title = {Significant kidney disease in pregnancy: Feasibility and outcomes of a national population‐based study using the Australasian Maternity Outcomes Surveillance System},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2025},
  doi = {10.1111/ajo.13885}
}
Kostenlos starten →